Active substance
Results for the substance ivosidenib
1 result
About this active substance
Ivosidenib is a medication used to treat acute myeloid leukemia (AML) in adult patients with an IDH1 mutation. It works by inhibiting the mutant IDH1 enzyme, reducing the proliferation of cancer cells.
The medication is taken orally, usually once daily, as directed by a doctor.
Side effects may include nausea, fatigue, diarrhea, fever, or changes in liver function. In rare cases, severe adverse effects such as differentiation syndrome or cardiac arrhythmias may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
The medication is taken orally, usually once daily, as directed by a doctor.
Side effects may include nausea, fatigue, diarrhea, fever, or changes in liver function. In rare cases, severe adverse effects such as differentiation syndrome or cardiac arrhythmias may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.